People with ANCA-associated vasculitis (AAV) are at a greater risk of venous thromboembolism — blood clots in veins —…
Articles by José Lopes, PhD
A new mouse model of ANCA-associated vasculitis (AAV) shows glomerulonephritis, lung vasculitis, and MPO-ANCA autoantibodies, among other alterations…
Although serum levels of the pro-inflammatory molecule interleukin (IL)-6 do not predict who will achieve complete remission, increases during periods…
Measuring structural features of specialized kidney cells called podocytes could predict short-term proteinuria — excess proteins in urine — in…
High blood pressure and other cardiovascular risk factors are highly prevalent in people with ANCA-associated vasculitis (AAV), and a…
Patients with ANCA-associated vasculitis (AAV) experience significant increases in serum lipid levels during remission induction, particularly those who are…
Patients with ANCA-associated vasculitis (AAV) with low levels of complement proteins develop greater kidney damage, according to new…
Testing positive for anti-PR3 antibodies and showing lesions in the lungs and cartilaginous tissues could replace nasal biopsy for…
Patients with ANCA-associated vasculitis (AAV) who have persistent antiphospholipid antibodies (APLAs) at diagnosis are at a greater risk of developing blood…
Dividing ANCA-associated vasculitis (AAV) into subgroups defined by type of antibodies does not provide additional value for clinical prognosis, according…